Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

BJU International

Volumn 99, Issue 1, 2007, Pages 162-165

  Forman, Colin J ^a   Johnson, David W ^a   Nicol, David L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Cytoprotection; Erythropoietin; Pigs; Renal ischaemic injury

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG MECHANISM; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY STRUCTURE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; SWINE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANIMALS; CELL DEATH; CREATININE; ERYTHROPOIETIN; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; REPERFUSION INJURY; SWINE; TREATMENT OUTCOME;

EID: 33845505734     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06505.x     Document Type: Article

References (18)

1. Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 2000; 161: 872-9
2. Weisberg LS, Allgren RL, Genter FC, Kurnik BR. Cause of acute tubular necrosis affects its prognosis. The Auriculin Anaritide Acute Renal Failure study group. Arch Intern Med 1997; 157: 1833-8
3. Barretti P, Soares VA. Acute renal failure: clinical outcome and causes of death. Ren Fail 1997; 19: 253-7
4. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17: 1143-50
5. Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004; 43: 649-59
6. Farrell F, Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 2004; 9(Suppl. 5): 18-30
7. Westenfelder C, Biddle DL, Baranowski RL. Human, rat and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-20
8. Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK. Cytoprotection by darbepoietin/epoetin alpha in pig tubular and mouse mesangial cells. Kidney Int 2004; 65: 452-8
9. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-55
10. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/ reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-9
11. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-24
12. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278: F1-F12
13. Kerr JF, Gobe GC, Winterford CM, Harmon BV. Anatomical methods in cell death. Methods Cell Biol 1995; 46: 1-27
14. Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 454-67
15. Ganong WF. Review of Medical Physiology, 21st edn. New York: Lange Medical Books/Mc Graw-Hill, 1995: 709
16. Bagnis C, Beaufils H, Jacquiaud C et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 2001; 16: 932-8
17. Johnson DW, Forman CJ, Vesey DA. Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology. 2006 [Epub ahead of print], DOI 10.1111/j.1440-1797.2006.00585.x
18. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome C release from the mitochondria. Cell Death Differ 2006 [Epub ahead of print], 10.1038/sj.cdd.4401950